We are investigating how the enzyme myeloperoxidase kills bacteria but also promotes tissue damage in numerous inflammatory diseases including cystic fibrosis, IBD, rheumatoid arthritis and cancer.
This is one of a number of projects on offer for the 2024 intake of BBiomedSc(Hons) at the University of Otago, Christchurch campus.
- Bachelor of Biomedical Sciences with Honours (BBiomedSc(Hons)) at the University of Otago, Christchurch
- Dr Louisa Ashby
- Centre for Redox Biology and Medicine
- Department of Pathology and Biomedical Science
ContactDr Louisa Ashby
Similar research opportunities
- Antibiotic failure in tuberculosis due to interactions with myeloperoxidase, an enzyme released by immune cells
- Identifying the mechanism of action of a marine-derived anticancer compound
- Adipocyte markers as predictors of progression in men with prostate cancer
- Amyloids of p16 in cancer
- Analysis of the pharmacogene CYP2D6 using nanopore DNA sequencing system